Literature DB >> 23404407

Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas.

Wang Jia1, Runchun Lu, Guijun Jia, Ming Ni, Zhiqing Xu.   

Abstract

The purpose of this study was to elucidate the relationship between pituitary tumor transforming gene (PTTG) and invasiveness in pituitary macroadenomas and to determine the association between PTTG and both the tumor proliferative activity marker proliferation cell nuclear antigen (PCNA) and the angiogenic factor basic fibroblast growth factor. A total of 70 patients with pituitary adenomas who underwent transsphenoidal or craniotomy surgical resection were enrolled. The average age were 42.5 ± 13.7 years (17-64 years) for the invasive group and 46.8 ± 12.1 years (16-71 years) for the non-invasive group, with no significant difference (P=0.179) between the two groups. RT-PCR analysis of a group of pituitary macroadenomas demonstrated that the expression levels of PTTG and PCNA in invasive pituitary adenomas were significantly higher than in non-invasive pituitary adenomas. Both factors are both closely related to the invasive growth of pituitary adenomas and may possibly serve as important markers of this growth. In conclusion, PTTG may promote invasive tumor growth by stimulating pituitary adenomas proliferation. The mechanisms of tumor growth promotion and invasion of the surrounding structures by PTTG need to be further explored.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404407     DOI: 10.1007/s13277-013-0686-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

1.  Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).

Authors:  X Zhang; G A Horwitz; T R Prezant; A Valentini; M Nakashima; M D Bronstein; S Melmed
Journal:  Mol Endocrinol       Date:  1999-01

Review 2.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

Review 3.  Predictive markers of pituitary adenoma behavior.

Authors:  George Kontogeorgos
Journal:  Neuroendocrinology       Date:  2006-10-13       Impact factor: 4.914

Review 4.  Pituitary tumor transforming gene: an important gene in normal cellular functions and tumorigenesis.

Authors:  C Bradshaw; S S Kakar
Journal:  Histol Histopathol       Date:  2007-02       Impact factor: 2.303

5.  Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.

Authors:  I Shimon; D R Hinton; M H Weiss; S Melmed
Journal:  Clin Endocrinol (Oxf)       Date:  1998-01       Impact factor: 3.478

6.  The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.

Authors:  J A C Hunter; R H Skelly; S J B Aylwin; J F Geddes; J Evanson; G M Besser; J P Monson; J M Burrin
Journal:  Eur J Endocrinol       Date:  2003-02       Impact factor: 6.664

7.  Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.

Authors:  W Saeger; B Lüdecke; D K Lüdecke
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-12-10       Impact factor: 2.949

Review 8.  Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.

Authors:  Fateme Salehi; Kalman Kovacs; Bernd W Scheithauer; Ricardo V Lloyd; Michael Cusimano
Journal:  Endocr Relat Cancer       Date:  2008-09       Impact factor: 5.678

9.  Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

Authors:  S Ezzat; H S Smyth; L Ramyar; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

10.  Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.

Authors:  Erdener Ozer; M Serefettin Canda; Cagnur Ulukus; Merih Guray; Serhat Erbayraktar
Journal:  Tumori       Date:  2003 Jan-Feb
View more
  7 in total

1.  Securin promotes migration and invasion via matrix metalloproteinases in glioma cells.

Authors:  Haicheng Yan; Wei Wang; Changwu Dou; Fuming Tian; Songtao Qi
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

2.  Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13.

Authors:  Yun-Hua Lin; Yong Tian; Jun-Sheng Wang; Yong-Guang Jiang; Yong Luo; Ya-Tong Chen
Journal:  Tumour Biol       Date:  2015-07-23

Review 3.  Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  Diagnostics (Basel)       Date:  2022-04-13

4.  A pseudogene-signature in glioma predicts survival.

Authors:  Kai-Ming Gao; Xin-Cheng Chen; Jun-Xia Zhang; Yingyi Wang; Wei Yan; Yong-Ping You
Journal:  J Exp Clin Cancer Res       Date:  2015-03-04

5.  Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis.

Authors:  Jian-Qi Xiao; Xiao-Hai Liu; Bo Hou; Yong Yao; Kan Deng; Min Feng; Bin Xing; Wei Lian; Ren-Zhi Wang; Feng Feng
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

6.  Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.

Authors:  Zhen-Guo Zhao; De-Qiang Wang; De-Fei Hu; You-Sheng Li; Shuang-Hai Liu
Journal:  Onco Targets Ther       Date:  2016-03-23       Impact factor: 4.147

7.  The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.

Authors:  Hai-qian Liang; Ren-jie Wang; Cai-feng Diao; Jian-wei Li; Jing-liang Su; Sai Zhang
Journal:  Oncotarget       Date:  2015-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.